Angiogenic and Anti-Angiogenic Therapy for Gastrointestinal Ulcers: New Challenges for Rational Therapeutic Predictions and Drug Design

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|16|1633-1642

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.16, 2011-06, pp. : 1633-1642

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombospondins as Anti-Angiogenic Therapeutic Agents

By  

Current Pharmaceutical Design, Vol. 9, Iss. 7, 2003-03 ,pp. : 583-588

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-angiogenic therapy of proliferative diabetic retinopathy

By Danis R.P.   Ciulla T.A.   Criswell M.   Pratt L.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 3, 2001-03 ,pp. : 395-407

Informa Healthcare

Access to resources Recommend Favorite

Rhinitis and epistaxis in patients treated by anti-angiogenic therapy

By Prulière-Escabasse V.   Escudier E.   Balheda R.   Soria J.   Coste A.   Massard C.  

Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. : 285-286

Springer Publishing Company

Access to resources Recommend Favorite

Target-based Anti-angiogenic Therapy in Breast Cancer

By  

Current Pharmaceutical Design, Vol. 18, Iss. 27, 2012-09 ,pp. : 4244-4257

Bentham Science Publishers

Access to resources Recommend Favorite

Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 10, Iss. 8, 2010-12 ,pp. : 898-913

Bentham Science Publishers

Access to resources Recommend Favorite